You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 8, 2025

Details for Patent: 8,778,916


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 8,778,916 protect, and when does it expire?

Patent 8,778,916 protects JATENZO and is included in one NDA.

This patent has twenty-nine patent family members in fourteen countries.

Summary for Patent: 8,778,916
Title:Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same
Abstract: A pharmaceutical formulation of testosterone undecanoate is provided. Methods of treating a testosterone deficiency or its symptoms with the inventive formulations are also provided.
Inventor(s): Dudley; Robert E. (Rosemary Beach, FL), Constantinides; Panayiotis P. (Gurnee, IL)
Assignee: Clarus Therapeutics, Inc. (Northbrook, IL)
Application Number:13/584,958
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,778,916
Patent Claim Types:
see list of patent claims
Composition; Formulation; Dosage form;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 8,778,916

Introduction

Understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals to navigate the complex landscape of intellectual property. This article will delve into the specifics of United States Patent 8,778,916, focusing on its claims, scope, and the broader patent landscape.

Patent Overview

United States Patent 8,778,916, titled "Oral Pharmaceutical Composition," was granted to address specific needs in the pharmaceutical industry. Here is a brief overview of the patent:

Invention Description

The patent describes an oral pharmaceutical composition, particularly focusing on the formulation of testosterone undecanoate. The composition is designed to improve the bioavailability and stability of testosterone undecanoate when administered orally[5].

Claims Analysis

The claims section of a patent is critical as it defines the scope of the invention and what is protected by the patent.

Independent Claims

  • Claim 1: This is the broadest claim and sets the foundation for the invention. It describes an oral pharmaceutical composition comprising 18-22 percent by weight of solubilized testosterone undecanoate and 50-55 percent by weight of a solubilizing agent[5].

Dependent Claims

  • These claims further specify the components and their proportions, such as the type of solubilizing agents, other ingredients, and the formulation process. For example, dependent claims might specify the use of particular solubilizing agents like castor oil or medium-chain triglycerides.

Scope of the Patent

The scope of the patent is determined by the claims and the description provided in the specification.

Key Components

  • Testosterone Undecanoate: The patent focuses on the solubilization of testosterone undecanoate, which is a critical component for the oral delivery of testosterone.
  • Solubilizing Agents: The composition includes specific solubilizing agents that enhance the bioavailability of testosterone undecanoate.
  • Formulation: The patent details the formulation process, including the proportions of the ingredients and the method of preparation.

Protection and Limitations

The scope of the patent protects the specific formulation and composition described in the claims. However, it does not cover variations that fall outside these claims. For instance, using a different solubilizing agent or altering the proportions significantly would not be protected under this patent.

Patent Landscape

Understanding the broader patent landscape is essential to see how this patent fits into the larger scheme of intellectual property in the pharmaceutical industry.

Related Patents

  • Other patents related to oral pharmaceutical compositions, especially those involving testosterone formulations, can provide insight into the competitive landscape. For example, patents on different solubilizing agents or alternative formulations could be relevant[1].

Global Dossier and International Patents

Using tools like the Global Dossier, one can identify related patent applications filed in other countries. This helps in understanding the global protection and potential variations of the invention[1].

Patent Families

The patent family for this invention includes all related applications filed at participating IP Offices. This can be accessed through the Global Dossier service, providing a comprehensive view of the patent's international scope[1].

Economic and Legal Implications

The economic and legal implications of this patent are significant.

Market Impact

  • The patent can influence the market by providing a unique formulation that improves the bioavailability of testosterone undecanoate. This can lead to better treatment outcomes and potentially higher market share for the patent holder.
  • Competitors may need to develop alternative formulations to avoid infringement, driving innovation in the field.

Legal Considerations

  • The patent holder has the right to enforce the patent against infringers. This involves monitoring for unauthorized use and taking legal action if necessary.
  • The patent's validity can be challenged through various legal mechanisms, such as reexamination or litigation[2].

Data and Statistics

Analyzing data related to patent applications and grants can provide insights into the success rate and trends in the pharmaceutical industry.

Patent Allowance Rates

  • Studies on patent allowance rates, such as those conducted by the USPTO, can help in understanding the likelihood of similar patents being granted. For instance, the family allowance rate, which includes the outcomes of continuation applications, can be relevant[4].

Patent Claims Research Dataset

  • The USPTO's Patent Claims Research Dataset provides detailed information on claims from US patents and applications. This dataset can be used to analyze trends in patent scope and claims in the pharmaceutical sector[3].

Conclusion

Understanding the scope and claims of United States Patent 8,778,916 is crucial for anyone involved in the development, manufacturing, or legal aspects of oral pharmaceutical compositions. Here are the key takeaways:

  • Specific Claims: The patent protects a specific formulation of testosterone undecanoate with defined proportions of solubilizing agents.
  • Scope of Protection: The patent's scope is limited to the claims and does not cover significant variations.
  • Patent Landscape: The patent is part of a broader landscape that includes related patents and international filings.
  • Economic and Legal Implications: The patent can significantly impact the market and involves legal considerations for enforcement and validity.

Key Takeaways

  • Claims Analysis: Understand the independent and dependent claims to grasp the protected invention.
  • Scope of the Patent: Recognize what is protected and what is not to avoid infringement.
  • Patent Landscape: Use tools like the Global Dossier to understand the international scope.
  • Economic Impact: Consider the market implications and potential for innovation.
  • Legal Considerations: Be aware of the legal mechanisms for enforcement and challenging the patent.

FAQs

Q1: What is the main focus of United States Patent 8,778,916? The main focus is on an oral pharmaceutical composition containing solubilized testosterone undecanoate.

Q2: How can I determine if my formulation infringes on this patent? You need to compare your formulation against the claims of the patent, ensuring that your proportions and components do not fall within the protected scope.

Q3: Can I use this patent as a reference for developing a new formulation? Yes, but you must ensure that your new formulation does not infringe on the existing claims. You may need to consult with a patent attorney to ensure compliance.

Q4: How can I access related international patents? You can use the Global Dossier service provided by the USPTO to access related patent applications filed in other countries.

Q5: What are the economic implications of this patent? The patent can influence the market by providing a unique formulation, potentially leading to better treatment outcomes and higher market share for the patent holder, while driving competitors to innovate alternative formulations.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. ACUS - U.S. Patent Small Claims Court: https://www.acus.gov/research-projects/us-patent-small-claims-court
  3. USPTO - Patent Claims Research Dataset: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. YJOLT - What Is the Probability of Receiving a US Patent?: https://yjolt.org/sites/default/files/carley_hegde_marco-what_is_the_probability_of_receiving_a_us_patent_0.pdf
  5. DrugPatentWatch - Claims for Patent: 8778916: https://www.drugpatentwatch.com/p/patent-claims/8778916

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,778,916

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Tolmar JATENZO testosterone undecanoate CAPSULE;ORAL 206089-001 Mar 27, 2019 RX Yes No 8,778,916 ⤷  Subscribe Y ⤷  Subscribe
Tolmar JATENZO testosterone undecanoate CAPSULE;ORAL 206089-002 Mar 27, 2019 RX Yes No 8,778,916 ⤷  Subscribe Y ⤷  Subscribe
Tolmar JATENZO testosterone undecanoate CAPSULE;ORAL 206089-003 Mar 27, 2019 RX Yes Yes 8,778,916 ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 8,778,916

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2006236564 ⤷  Subscribe
Australia 2011201422 ⤷  Subscribe
Brazil PI0607549 ⤷  Subscribe
Canada 2604943 ⤷  Subscribe
China 101217963 ⤷  Subscribe
Denmark 2985026 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.